| Literature DB >> 35889054 |
Frederick Adzitey1, Saniyatu Yussif2, Roland Ayamga3, Sumaila Zuberu3, Francis Addy4, Gideon Adu-Bonsu4, Nurul Huda5, Rovina Kobun5.
Abstract
There is a rising concern about illnesses resulting from milk consumption due to contamination by pathogenic microorganisms including Escherichia coli. This study examined the occurrence and antimicrobial susceptibility of E. coli isolated from cow milk and related samples. Furthermore, partial sequencing was done to ascertain the genetic relatedness and possible cross contamination among the samples. In all, 250 samples, that is, 50 each of raw milk, cow teat, milkers' hands, milking utensils, and fecal matter of cows, were cultured for the identification of E. coli. E. coli was detected in 101/250 samples (40.4%). Milk and fecal samples recorded the highest percentages of 68.0% and 66.0%, respectively. Forty-two (42) E. coli strains examined for antimicrobial resistance showed an overall 25.5% resistance, 15.0% intermediate resistance, and 59.5% susceptibility. The isolates had a high level of resistance to teicoplanin (100.0%), but were susceptible to chloramphenicol (95.2%) and azithromycin (92.9%). The Multiple Antibiotic Resistance (MAR) index pattern ranged from 0.1 to 0.5, and 40.5% exhibited multiple drug resistance. The E. coli strains formed 11 haplotypes, and a phylogenic tree analysis showed relatedness among the isolates in other African countries. This observation is an indication of cross contamination among the milk and its related samples.Entities:
Keywords: E. coli; Ghana; antimicrobial; milk; molecular; partial sequencing
Year: 2022 PMID: 35889054 PMCID: PMC9320388 DOI: 10.3390/microorganisms10071335
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Occurrence of E. coli in raw cow’s milk and related samples.
| Sample Type | Number of Samples | Number of Positives | % Occurrence |
|---|---|---|---|
| Milk | 50 | 34 | 68.0 |
| Feces | 50 | 33 | 66.0 |
| Utensils | 50 | 21 | 42.0 |
| Teat | 50 | 7 | 14.0 |
| Hands | 50 | 6 | 12.0 |
| Overall | 250 | 101 | 40.4 |
Percentage of Antimicrobial Susceptibility of E. coli.
| Antibiotics | % Resistance | % Intermediate Resistance | % Susceptibility |
|---|---|---|---|
| Amoxycillin (A) 30 µg | 50.0 | 47.6 | 2.4 |
| Azithromycin (Azm) 15 µg | 0.0 | 7.1 | 92.9 |
| Ceftriaxone (Cro) 30 µg | 9.5 | 31.0 | 59.5 |
| Chloramphenicol (C) 30 µg | 2.4 | 2.4 | 95.2 |
| Ciprofloxacin (Cip) 5 µg | 19.0 | 26.2 | 54.8 |
| Gentamicin (Gm) 10 µg | 2.4 | 14.3 | 83.3 |
| Imipenem (Imi) 10 µg | 9.5 | 16.7 | 73.8 |
| Teicoplanin (Tec) 30 µg | 100.0 | 0.0 | 0.0 |
| Tetracycline (Te) 30 µg | 35.7 | 2.4 | 61.9 |
| Sulphamethoxazole/trimethoprim (Sxt) 22 µg | 26.2 | 2.4 | 71.4 |
| Overall | 25.5 | 15.0 | 59.5 |
Antibiotic Resistance Profile and Multiple Antibiotic Resistant Index of Individual E. coli.
| Isolate Code | Sources | No. of Antibiotics | Antibiotics Resistance | MAR Index |
|---|---|---|---|---|
| FS17 | Fecal | 2 | Tec-Te | 0.2 |
| FS22 | Fecal | 5 | A-Tec-T-Cro-Sxt | 0.5 |
| FS25 | Fecal | 1 | Tec | 0.1 |
| FS34 | Fecal | 4 | Cip-Tec-Te-Sxt | 0.4 |
| FS48 | Fecal | 4 | Cip-Tec-Te-Sxt | 0.4 |
| FS5 | Fecal | 2 | Tec-Imi | 0.2 |
| FS50 | Fecal | 1 | Tec | 0.1 |
| FS6 | Fecal | 1 | Tec | 0.1 |
| FS8 | Fecal | 1 | Tec | 0.1 |
| HS1 | Hand | 2 | A-Tec | 0.2 |
| HS11 | Hand | 4 | Cip-A-Tec-Te | 0.4 |
| HS12 | Hand | 3 | A-Tec-Te | 0.3 |
| HS18 | Hand | 1 | Tec | 0.1 |
| HS3 | Hand | 3 | A-Tec-Te | 0.3 |
| HS9 | Hand | 1 | Tec | 0.1 |
| M15 | Milk | 1 | Tec | 0.1 |
| M17 | Milk | 1 | Tec | 0.1 |
| M2 | Milk | 1 | Tec | 0.1 |
| M25 | Milk | 2 | A-Tec | 0.2 |
| M39 | Milk | 4 | A-Tec-Cro-Imi | 0.4 |
| M45 | Milk | 2 | A-Tec | 0.2 |
| M50 | Milk | 4 | A-Tec-Te-Sxt | 0.4 |
| M51 | Milk | 1 | Tec | 0.1 |
| M6 | Milk | 5 | A-Tec-C-Cro-Sxt | 0.5 |
| M9 | Milk | 5 | A-Tec-Te-Gm-Sxt | 0.5 |
| TS1 | Teat | 1 | Tec | 0.1 |
| TS10 | Teat | 4 | A-Tec-Te-Imi | 0.4 |
| TS20 | Teat | 2 | A-Tec | 0.2 |
| TS26 | Teat | 5 | Cip-A-Tec-Te-Sxt | 0.5 |
| TS27 | Teat | 1 | Tec | 0.1 |
| TS36 | Teat | 2 | Cip-Tec | 0.2 |
| TS45 | Teat | 3 | Tec-Cro-Sxt | 0.3 |
| TS9 | Teat | 3 | A-Tec-Imi | 0.3 |
| US18 | Utensils | 2 | Tec-Te | 0.2 |
| US2 | Utensils | 2 | A-Tec | 0.2 |
| US24 | Utensils | 5 | Cip-A-Tec-Te-Sxt | 0.5 |
| US3 | Utensils | 5 | Cip-A-Tec-Te-Sxt | 0.5 |
| US30 | Utensils | 5 | Cip-A-Tec-Te-Sxt | 0.5 |
| US31 | Utensils | 2 | A-Tec | 0.2 |
| US34 | Utensils | 2 | A-Tec | 0.2 |
| US49 | Utensils | 1 | Tec | 0.1 |
| US5 | Utensils | 1 | Tec | 0.1 |
Key: Ceftriaxone (Cro) 30 µg (Cephalosporins), Chloramphenicol (C) 30 µg (Chloramphenicol), Gentamicin (Gm) 10 µg (Aminoglycosides), Suphamethoxazole/trimethoprim (Sxt) 22 µg (Sulfonamides), Ciprofloxacin (Cip) 5 µg (Quinolones), Tetracycline (Te) 30 µg (Tetracyclines), Imipenem (Imi) 10 µg (Carbapenem), Amoxycillin (A) 30 μg (Penicillins), Azithromycin (Azm) 15 µg (Macrolides), and Teicoplanin (Tec) 30 µg (Glycopeptides). MAR index = a/b, where “a” represents the number of antibiotics to which the isolate was resistant, and “b” represents the number of antibiotics to which the isolate was exposed [17].
Figure 1Agarose gel photo obtained from PCR products for identification of E. coli. M/L: Quick-Load® Purple 100 bp DNA Ladder (New England Biolabs); A1 (Positive control, ATCC 25922); B1–J1 (E. coli isolates, ~147 bp); N/C: Negative control.
Nucleotide identity of E. coli isolates in the present study compared with reference gene in the GenBank.
| Haplotypes (Isolates) | Gene Bank Reference | Country | Percentage Identity (%) | |
|---|---|---|---|---|
| Hap 01 (Us2, Us30, Us34, Hs1, Hs18, Fs6, M15) | STEC2017-197 | CP075663.1 | Switzerland | 98.97 |
| Hap 02 (Us18) | KCJ3K291 | CP054407.1 | USA | 98.95 |
| Hap 03 (M23) | STW0522-31 | AP022409.1 | Japan | 98.92 |
| Hap 04 (Fs5) | O176:H45 strain MIN9 chromosome | CP069682.1 | Poland | 97.92 |
| Hap 05 (Fs25) | 19-5 chromosome | CP047010.1 | China | 98.91 |
| Hap 06 (M22) | EH10-18-47 | CP063499.1 | Laos | 100 |
| Hap 07 (M17, M45, M46) | STEC2018-553 | CP075665.5 | Switzerland | 100 |
| Hap 08 (Ts26, Fs50, M51) | STEC- 183 chromosome | CP0756971.1 | Switzerland | 98.95 |
| Hap 09 (Ts 20) | SH9PTE6 | CP073768.1 | China | 100 |
| Hap 10 (Ts1) | EcPF20 | CP071441.1 | USA | 98.25 |
| Hap 11 (M36, Ts 36) | TW10722 | CP035841.1 | Guinea Bissau | 96.84 |
Figure 2E. coli uidA (~147 bp) haplotype network of sequences from present study. Circle size indicate the frequency of haplotype in the dataset and the strokes refer to mutational steps.
Figure 3Maximum-likelihood Phylogenetic tree of E. coli based on the sequences of uidA gene sourced from repository of GenBank. Sequences of the present study are denoted GHA1-11 on the tree with Pseudomonas aeruginosa as outgroup.